Published in J Neuroinflammation on March 31, 2011
Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation. Front Cell Neurosci (2013) 1.20
Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. PLoS One (2014) 0.90
Modulation of interferon-γ-induced glial cell activation by transforming growth factor β1: a role for STAT1 and MAPK pathways. J Neurochem (2012) 0.85
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation. J Neuroinflammation (2012) 0.83
Influence of aging on Bmal1 and Per2 expression in extra-SCN oscillators in hamster brain. Brain Res (2012) 0.82
Bone marrow-derived macrophages from aged rats are more responsive to inflammatory stimuli. J Neuroinflammation (2015) 0.82
Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms. Mol Brain (2014) 0.81
Role of TGFβ signaling in the pathogenesis of Alzheimer's disease. Front Cell Neurosci (2015) 0.77
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature (2002) 5.24
Immune activation in brain aging and neurodegeneration: too much or too little? Neuron (2009) 3.76
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med (1999) 3.08
Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol (1994) 2.69
The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol (2007) 2.68
Expression and regulation of chemokine receptors in human natural killer cells. Blood (2001) 1.74
Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum. Neuropathol Appl Neurobiol (2010) 1.65
beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol (2000) 1.40
CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology (1999) 1.26
Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J (2006) 1.25
Microglia and macrophages as innate producers of interferon-gamma in the brain following infection with Toxoplasma gondii. Int J Parasitol (2004) 1.24
Molecular regulation of CD40 gene expression in macrophages and microglia. Brain Behav Immun (2004) 1.18
IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro. J Neurochem (2007) 1.14
A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain. J Biol Chem (2007) 1.05
Interaction between interferon gamma and insulin-like growth factor-1 in hippocampus impacts on the ability of rats to sustain long-term potentiation. J Neurochem (2006) 1.03
A novel anti-inflammatory role of NCAM-derived mimetic peptide, FGL. Neurobiol Aging (2008) 1.00
Reproductive age-related changes in the blood brain barrier: expression of IgG and tight junction proteins. Microvasc Res (2009) 0.99
Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells. Vet Immunol Immunopathol (2007) 0.94
Signaling through MyD88 regulates leukocyte recruitment after brain injury. J Immunol (2008) 0.93
Expression of tumour necrosis factor-alpha, -beta and interferon-gamma genes within human neuroglial tumour cells and brain specimens. Cytokine (1994) 0.93
Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP. Neurobiol Aging (2010) 0.92
Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway. Neurobiol Aging (2000) 0.88
A synthetic NCAM-derived mimetic peptide, FGL, exerts anti-inflammatory properties via IGF-1 and interferon-gamma modulation. J Neurochem (2009) 0.87
The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo. Neuropharmacology (2006) 0.87
Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis. Int Immunol (2006) 0.86
Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats. Brain Res (2005) 0.86
Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun (2010) 1.93
The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem (2006) 1.76
CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J Neurosci (2007) 1.51
Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro. J Neurochem (2009) 1.45
Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10--a role for IL-1 beta? J Neurochem (2004) 1.31
Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1 beta on long term potentiation in rat dentate gyrus. J Biol Chem (2003) 1.24
Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J Biol Chem (2004) 1.20
Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms. J Biol Chem (2008) 1.19
BDNF-induced LTP in dentate gyrus is impaired with age: analysis of changes in cell signaling events. Neurobiol Aging (2004) 1.18
Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat. Neurobiol Aging (2005) 1.16
Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction. J Neurochem (2011) 1.15
IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro. J Neurochem (2007) 1.14
Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide. Brain Behav Immun (2009) 1.09
Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain. Neurobiol Aging (2007) 1.06
A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain. J Biol Chem (2007) 1.05
Interaction between interferon gamma and insulin-like growth factor-1 in hippocampus impacts on the ability of rats to sustain long-term potentiation. J Neurochem (2006) 1.03
Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid. J Biol Chem (2002) 1.03
IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. J Immunol (2013) 1.03
Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: a role for interleukin-1beta? J Biol Chem (2003) 1.02
Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus. Neurobiol Aging (2006) 1.02
Intra- and inter-nucleosome interactions of the core histone tail domains in higher-order chromatin structure. Chromosoma (2013) 1.02
The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat. Neurobiol Aging (2010) 1.01
Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: a role for Toll-like receptor activation. J Biol Chem (2011) 1.00
A novel anti-inflammatory role of NCAM-derived mimetic peptide, FGL. Neurobiol Aging (2008) 1.00
The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur J Neurosci (2002) 1.00
Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation. J Biol Chem (2002) 0.98
Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines. J Infect Dis (2005) 0.96
The impact of glial activation in the aging brain. Aging Dis (2010) 0.95
CD200 fusion protein decreases microglial activation in the hippocampus of aged rats. Brain Behav Immun (2011) 0.94
IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8. J Neurochem (2008) 0.92
Amyloid-β-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE. J Neuroimmune Pharmacol (2012) 0.92
Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP. Neurobiol Aging (2010) 0.92
Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress. J Alzheimers Dis (2012) 0.91
Classical activation of microglia in CD200-deficient mice is a consequence of blood brain barrier permeability and infiltration of peripheral cells. Brain Behav Immun (2013) 0.91
Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice. Neurobiol Aging (2013) 0.91
Evidence that lipopolysaccharide-induced cell death is mediated by accumulation of reactive oxygen species and activation of p38 in rat cortex and hippocampus. Exp Neurol (2003) 0.90
Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice. J Neurosci (2011) 0.90
Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages. Eur J Immunol (2014) 0.88
Expression of long-term potentiation in aged rats involves perforated synapses but dendritic spine branching results from high-frequency stimulation alone. Hippocampus (2004) 0.88
A neural cell adhesion molecule-derived peptide, FGL, attenuates glial cell activation in the aged hippocampus. Exp Neurol (2011) 0.87
The age-related deficit in LTP is associated with changes in perfusion and blood-brain barrier permeability. Neurobiol Aging (2011) 0.87
A synthetic NCAM-derived mimetic peptide, FGL, exerts anti-inflammatory properties via IGF-1 and interferon-gamma modulation. J Neurochem (2009) 0.87
The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo. Neuropharmacology (2006) 0.87
Differential phosphorylation of Smad1 integrates BMP and neurotrophin pathways through Erk/Dusp in axon development. Cell Rep (2013) 0.87
Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in glia. J Neuroinflammation (2012) 0.87
Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor. J Neuroimmunol (2003) 0.86
LPS-induced release of IL-6 from glia modulates production of IL-1β in a JAK2-dependent manner. J Neuroinflammation (2012) 0.86
Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid. J Neurochem (2007) 0.86
Treatment with dexamethasone and vitamin D3 attenuates neuroinflammatory age-related changes in rat hippocampus. Synapse (2007) 0.86
Neuroprotective actions of eicosapentaenoic acid on lipopolysaccharide-induced dysfunction in rat hippocampus. J Neurochem (2004) 0.86
The neuroprotective effect of a specific P2X₇ receptor antagonist derives from its ability to inhibit assembly of the NLRP3 inflammasome in glial cells. Brain Pathol (2011) 0.86
Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-β. Hippocampus (2013) 0.85
Ischemic brain injury: a consortium analysis of key factors involved in mesenchymal stem cell-mediated inflammatory reduction. Arch Biochem Biophys (2013) 0.84
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation. J Neuroinflammation (2012) 0.83
SIGIRR modulates the inflammatory response in the brain. Brain Behav Immun (2010) 0.83
Activation of c-Jun-N-terminal kinase is critical in mediating lipopolysaccharide-induced changes in the rat hippocampus. J Neurochem (2005) 0.82
The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo. Hippocampus (2009) 0.82
IL-1beta-dependent neurological effects of the whole cell pertussis vaccine: a role for IL-1-associated signalling components in vaccine reactogenicity. J Neuroimmunol (2003) 0.81
Replication-independent nucleosome exchange is enhanced by local and specific acetylation of histone H4. Nucleic Acids Res (2013) 0.81
Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia. Mol Cell Neurosci (2013) 0.80
Glial uptake of amyloid beta induces NLRP3 inflammasome formation via cathepsin-dependent degradation of NLRP10. Neuromolecular Med (2013) 0.80
Activation of the P2X₇ receptor induces migration of glial cells by inducing cathepsin B degradation of tissue inhibitor of metalloproteinase 1. J Neurochem (2012) 0.80
Analysis of interleukin-1 beta-induced cell signaling activation in rat hippocampus following exposure to gamma irradiation. Protective effect of eicosapentaenoic acid. J Biol Chem (2003) 0.80
Neuroinflammatory changes increase the impact of stressors on neuronal function. Biochem Soc Trans (2009) 0.79
Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation. Prostaglandins Leukot Essent Fatty Acids (2004) 0.79
Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells. Brain Behav Immun (2010) 0.79
An NCAM mimetic, FGL, alters hippocampal cellular morphometry in young adult (4 month-old) rats. Neurochem Res (2012) 0.79
A novel phospholipid-based drug formulation, VP025, modulates age- and LPS-induced microglial activity in the rat. Neuroimmunomodulation (2009) 0.78
The age-related gliosis and accompanying deficit in spatial learning are unaffected by dimebon. Neurochem Res (2012) 0.78
Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's Immune Modulation Therapy. Neuroimmunomodulation (2002) 0.78
Identifying early inflammatory changes in monocyte-derived macrophages from a population with IQ-discrepant episodic memory. PLoS One (2013) 0.77
Evidence of an anti-inflammatory role for Vasogen's immune modulation therapy. Neuroimmunomodulation (2005) 0.77
EXPERIMENTAL CHALLENGE STUDY OF FV3-LIKE RANAVIRUS INFECTION IN PREVIOUSLY FV3-LIKE RANAVIRUS INFECTED EASTERN BOX TURTLES (TERRAPENE CAROLINA CAROLINA) TO ASSESS INFECTION AND SURVIVAL. J Zoo Wildl Med (2015) 0.76
The age- and amyloid-β-related increases in Nogo B contribute to microglial activation. Neurochem Int (2010) 0.76
Glial Activation in AβPP/PS1 Mice is Associated with Infiltration of IFNγ-Producing Cells. J Alzheimers Dis (2013) 0.76
The deficit in long-term potentiation induced by chronic administration of amyloid-beta is attenuated by treatment of rats with a novel phospholipid-based drug formulation, VP025. Exp Gerontol (2008) 0.75
RANAVIRUS EPIZOOTIC IN CAPTIVE EASTERN BOX TURTLES (TERRAPENE CAROLINA CAROLINA) WITH CONCURRENT HERPESVIRUS AND MYCOPLASMA INFECTION: MANAGEMENT AND MONITORING. J Zoo Wildl Med (2016) 0.75